Expression of survivin and XIAP for DMBA-induced hamster buccal pouch squamous cell carcinogenesis is associated with p53 accumulation

Oral Oncology

Volumn 44, Issue 1, 2008, Pages 43-49

  Hsue, Shue Sang ^a   Chen, Yuk Kwan ^a   Lin, Li Min ^a  

^a Faculty of Dentistry   (Taiwan)

Author keywords

IAP; p53; Survivin; XIAP

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; MINERAL OIL; PROTEIN P53; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CHEEK POUCH SQUAMOUS CELL CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RANDOMIZATION; SYRIAN HAMSTER;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CHEEK; CRICETINAE; IMMUNOHISTOCHEMISTRY; MALE; MESOCRICETUS; MICROTUBULE-ASSOCIATED PROTEINS; MOUTH NEOPLASMS; NEOPLASM PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 37149045892     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.12.009     Document Type: Article

References (53)

1. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 (1972) 239-257
2. Soini Y., Paakko P., and Lehto V.P. Histopathological evaluation of apoptosis in cancer. Am J Pathol 153 (1998) 1041-1053
3. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
4. Reed J.C. Mechanisms of apoptosis. Am J Pathol 157 (2000) 1415-1430
5. Reed J.C. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 34 (1997) 9-19
6. Reed J.C. Bcl-2 family proteins. Oncogene 17 (1998) 3225-3236
7. Clem R.J., Fechheimer M., and Miller L.K. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 254 (1991) 1388-1390
8. Deveraux Q.L., and Reed J.C. IAP family proteins: suppressors of apoptosis. Genes Dev 13 (1999) 239-252
9. Takahashi R., Deveraux Q., Tamm I., Welsh K., Assa-Munt N., Salvesen G.S., et al. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 273 (1998) 7787-7790
10. Altieri D.C., and Marchisio C. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79 (1999) 1327-1333
11. Yamamoto T., and Tanigawa N. The role of survivin as a new target of diagnosis and treatment in human cancer. Med Electron Microsc 34 (2001) 207-212
12. Tamm I., Want Y., Sausville E., Scudiero D.A., Vigna N., Oltersdorf T., et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 59 (1998) 5315-5320
13. Altieri D.C. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22 (2003) 8581-8589
14. Kajiwara Y., Yamasaki F., Hama S., Yahara K., Yoshioka H., Sugiyama K., et al. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer 97 (2003) 1077-1083
15. Islam A., Kageyama H., Takada N., Kawamoto T., Takayasu H., Isogai E., et al. High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19 (2000) 617-623
16. Ambrosini G., Adida C., and Altieri D. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3 (1997) 917-921
17. Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388 (1997) 300-304
18. Deveraux Q.L., Roy N., Stennicke H.R., Van Arsdale T., Zhou Q., Srinivasula S.M., et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17 (1998) 2215-2223
19. Liston P., Roy N., Tamai K., Lefebvre C., Baird S., Cherton-Horvat G., et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379 (1996) 349-353
20. Harlin H., Reffey S.B., Duckett C.S., Lindsten T., and Thompson C.B. Characterization of XIAP-deficient mice. Mol Cell Biol 21 (2001) 3604-3608
21. Li J., Kim J.M., Liston P., Li M., Miyazaki T., Mackenzie A.E., et al. Expression of inhibitor of apoptosis proteins (IAPs) in rat granulosa cells during ovarian follicular development and atresia. Endocrinology 139 (1998) 1321-1328
22. Gottlieb T.M., and Oren M. p53 and apoptosis. Sem Cancer Biol 8 (1998) 359-368
23. Gimenez-Conti I.B., LaBate M., Liu F., and Osterndorff E. p53 alterations in chemically induced hamster cheek-pouch lesions. Mol Carcinogenesis 16 (1996) 197-202
24. Chang K.W., Sarraj S., Lin S.C., Tsai P.I., and Solt D. p53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 21 (2000) 1441-1451
25. Chen Y.K., Hsue S.S., and Lin L.M. Correlation between inducible nitric oxide synthase and p53 expression for DMBA-induced hamster buccal-pouch carcinomas. Oral Dis 9 (2003) 227-234
26. Gimenez-Conti I.B., and Slaga T.J. The hamster cheek pouch carcinogenesis model. J Cell Biochem 17F Suppl. (1993) 83-90
27. Morris A.L. Factors influencing experimental carcinogenesis in the hamster cheek pouch. J Dent Res 40 (1961) 3-15
28. Lin L.M., and Chen Y.K. Diurnal variation of γ-glutamyl transpeptidase activity during DMBA-induced hamster buccal pouch carcinogenesis. Oral Dis 3 (1997) 153-156
29. Hsu S.M., Raine L., and Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29 (1981) 577-580
30. Barnes N., Haywood P., Flint P., Knox W.F., and Bundred N.J. Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. Br J Cancer 94 (2006) 253-258
31. Liston P., Fong W.G., Kelly N.L., Toji S., Miyazaki T., Conte D., et al. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol 3 (2001) 128-133
32. Vojtesek B., Bartek J., Midgley C.A., and Lane D.P. An immunohistochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Meth 151 (1992) 237-244
33. LaCasse E.C., Baird S., Korneluk R.G., and MacKenzie A.E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17 (1998) 3247-3259
34. Lo Muzio L., Staibano S., Pannone G., Mignogna M.D., Mariggio A., Salvatore G., et al. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 70 (2001) 249-254
35. Tanaka C., Uzawa K., Shibahara T., Yokoe H., Noma H., and Tanzawa H. Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res 82 (2003) 607-611
36. Lo Muzio L., Pannone G., Leonardi R., Staibano S., Mignogna M.D., De Rosa G., et al. Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res 82 (2003) 923-928
37. Lo Muzio L., Pannone G., Staibano S., Mignogna M.D., Rubini C., Mariggio M.A., et al. Survivin expression in oral squamous cell carcinoma. Br J Cancer 89 (2003) 2244-2248
38. Kim M.J., Lim K.Y., Kim J.W., Nam I.W., Lee J.H., and Myoung H. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma. Cancer Lett 224 28 (2005) 253-261
39. Lo Muzio L., Farina A., Rubini C., Pezzetti F., Stabellini G., Laino G., et al. Survivin as prognostic factor in squamous cell carcinoma of the oral cavity. Cancer Lett 225 (2005) 27-33
40. Lin C.Y., Hung H.C., Kuo R.C., Chiang C.P., and Kuo M.Y. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. Oral Oncol 41 (2005) 645-654
41. Marioni G., Bedogni A., Giacomelli L., Ferraro S.M., Bertolin A., Facco E., et al. Survivin expression is significantly higher in pN+ oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas. Acta Otolaryngol 125 (2005) 1218-1223
42. Tanimotoa T., Tsudaa H., Imazekia N., Ohnob Y., Imoto I., Inazawa J., et al. Nuclear expression of cIAP-1, an apoptosis protein, inhibiting in head and neck squamous cell carcinomas predicts lymph node metastasis and poor patient prognosis. Cancer Lett 224 (2005) 141-151
43. Jane C., Nerurkar A.V., Shirsat N.V., Deshpande R.B., Amrapurkar A.D., and Karjodkar F.R. Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers. J Oral Pathol Med 35 (2006) 595-601
44. Chen Y.K., Hsue S.S., and Lin L.M. Survivin expression is regulated by an epigenetic mechanism for DMBA-induced hamster buccal-pouch squamous-cell carcinomas. Arch Oral Biol 50 (2005) 593-598
45. Matsumiya T., Imaizumi T., Yoshida H., Kimura H., and Satoh K. Cisplatin inhibits the expression of X-chromosome-linked inhibitor of apoptosis protein in an oral carcinoma cell line. Oral Oncol 37 (2001) 296-300
46. Song Z., Yao X., and Wu M. Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis. J Biol Chem 278 (2003) 23130-23140
47. Altieri D.C. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7 (2001) 542-547
48. Mirza A., McGuirk M., Hockenberry T.N., Wu Q., Ashar H., Black S., et al. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21 (2002) 2613-2622
49. Hoffman W.H., Biade S., Zilfou J.T., Chen J., and Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277 (2002) 3247-3257
50. Wang L.D., Shi S.T., Zhou Q., Goldstein S., Hong J.Y., Shao P., et al. Changes in p53 and cyclin D1protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int J Cancer 59 (1994) 514-519
51. Li F., Ackermann E., Bennett C., Rothermel A., Plescia J., Tognin S., et al. Pleiotropic cell division defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1 (1999) 461-466
52. Sasaki H., Sheng Y., Kotsuji F., and Tsang B.K. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 60 (2000) 5659-5666
53. Li J., Feng Q., Kim J.M., Schneiderman D., Liston P., Li M., et al. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology 142 (2001) 370-380